Glutamate Metabolism in Major Depressive Disorder

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

Provencher, S. W. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300604 · Cited by 3,659 · see citing works

Grand challenges in global mental health

Collins, P. Y., Patel, V., Joestl, S. S., March, D., Insel, T. R., Daar, A. S., Bordin, I. A., Costello, E. J., Durkin, M., Fairburn, C., et al. (2011) · Nature · doi:10.1038/475027a · Cited by 2,043 · see citing works

The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393 · see citing works

The GABAergic deficit hypothesis of major depressive disorder

Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934 · see citing works

Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression

Sanacora, G., Gueorguieva, R. V., Epperson, C. N., Wu, Y., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796 · see citing works

Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue

Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603 · see citing works

Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex

Yuen, E. Y., Wei, J., Liu, W., Zhong, P., Li, X., & Yan, Z. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.033 · Cited by 558 · see citing works

Functional neuroimaging studies of depression: The anatomy of melancholia

Drevets, W. C. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.341 · Cited by 500 · see citing works

Impaired mitochondrial function in psychiatric disorders

Manji, H. K., Kato, T., Prospero, N. A. D., Ness, S. L., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3229 · Cited by 478 · see citing works

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole

Banasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458 · see citing works

Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond

Krystal, J. H., Sanacora, G., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.026 · Cited by 406 · see citing works

GABA and mood disorders: a brief review and hypothesis

Petty, F. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00025-i · Cited by 378 · see citing works

GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications

Conti, F., Minelli, A., & Melone, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.03.003 · Cited by 354 · see citing works

The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex <i>in vivo</i>

Patel, A. B., de Graaf, R. A., Mason, G. F., Rothman, D. L., Shulman, R. G., & Behar, K. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501703102 · Cited by 343 · see citing works

¹³ C MRS studies of neuroenergetics and neurotransmitter cycling in humans

Rothman, D. L., De Feyter, H. M., de Graaf, R. A., Mason, G. F., & Behar, K. L. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1772 · Cited by 290 · see citing works

Discovering imaging endophenotypes for major depression

Hasler, G., & Northoff, G. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.23 · Cited by 274 · see citing works

Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels

Hyder, F., Rothman, D. L., & Bennett, M. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214912110 · Cited by 271 · see citing works

Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder

Price, R. B., Shungu, D. C., Mao, X., Nestadt, P., Kelly, C., Collins, K. A., Murrough, J. W., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.025 · Cited by 270 · see citing works

Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder

Levinson, A. J., Fitzgerald, P. B., Favalli, G., Blumberger, D. M., Daigle, M., & Daskalakis, Z. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.025 · Cited by 261 · see citing works

Localized 13C NMR Spectroscopy in the Human Brain of Amino Acid Labeling from d ‐[1‐13C]Glucose

Rolf Gruetter, A., Novotny, E. J., Boulware, S. D., Mason, G. F., Rothman, D. L., Shulman, G. I., Prichard, J. W., & Shulman, R. G. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63041377.x · Cited by 244 · see citing works

From Pathophysiology to Novel Antidepressant Drugs: Glial Contributions to the Pathology and Treatment of Mood Disorders

Sanacora, G., & Banasr, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.032 · Cited by 239 · see citing works

Altered Brain Mitochondrial Metabolism in Healthy Aging as Assessed by in vivo Magnetic Resonance Spectroscopy

Boumezbeur, F., Mason, G. F., de Graaf, R. A., Behar, K. L., Cline, G. W., Shulman, G. I., Rothman, D. L., & Petersen, K. F. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.197 · Cited by 238 · see citing works

Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of 1H-MRS findings.

Luykx, J. J., Laban, K. G., van den Heuvel, M. P., Boks, M. P. M., Mandl, R. C. W., Kahn, R. S., & Bakker, S. C. (2012) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.05.014 · Cited by 235 · see citing works

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS

Valentine, G. W., Mason, G. F., Gomez, R., Fasula, M. K., Watzl, J., Pittman, B. P., Krystal, J. H., & Sanacora, G. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.10.009 · Cited by 205 · see citing works

High‐field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy

Petroff, O. A. C., Spencer, D. D., Alger, J. R., & Prichard, J. W. (1989) · Neurology · doi:10.1212/wnl.39.9.1197 · Cited by 203 · see citing works

Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology

Shungu, D. C., Weiduschat, N., Murrough, J. W., Mao, X., Pillemer, S., Dyke, J. P., Medow, M. S., Natelson, B. H., Stewart, J. M., & Mathew, S. J. (2012) · NMR in Biomedicine · doi:10.1002/nbm.2772 · Cited by 179 · see citing works

Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study

Moore, C. M., Christensen, J. D., Lafer, B., D, M. F. M., & Renshaw, P. F. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.116 · Cited by 168 · see citing works

Multinuclear Magnetic Resonance Spectroscopy Studies of Brain Purines in Major Depression

Renshaw, P. F., Parow, A. M., Hirashima, F., Ke, Y., Moore, C. M., Frederick, B. B., D, M. F. M., Hennen, J. A., & Cohen, B. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2048 · Cited by 132 · see citing works

1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism

Chowdhury, G. M. I., Behar, K. L., Cho, W., Thomas, M. A., Rothman, D. L., & Sanacora, G. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.006 · Cited by 125 · see citing works

Roles and regulation of glutamate transporters in the central nervous system

O'Shea, R. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03770.x · Cited by 121 · see citing works

Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression☆

Keedwell, P. A., Drapier, D., Surguladze, S., Giampietro, V., Brammer, M., & Phillips, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.031 · Cited by 106 · see citing works

Potential of Pretreatment Neural Activity in the Visual Cortex During Emotional Processing to Predict Treatment Response to Scopolamine in Major Depressive Disorder

Furey, M. L., Drevets, W. C., Hoffman, E. M., Frankel, E., Speer, A. M., & Zarate, C. A. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.60 · Cited by 102 · see citing works

Glutamatergic and GABA ergic energy metabolism measured in the rat brain by 13C NMR spectroscopy at 14.1 T

Duarte, J. M. N., & Rolf Gruetter, A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12333 · Cited by 81 · see citing works

A comparison of 13C NMR measurements of the rates of glutamine synthesis and the tricarboxylic acid cycle during oral and intravenous administration of [1-13C]glucose

Mason, G. F., Petersen, K. F., de Graaf, R. A., Kanamatsu, T., Otsuki, T., & Rothman, D. L. (2003) · Brain Research Protocols · doi:10.1016/s1385-299x(02)00217-9 · Cited by 79 · see citing works

Basic principles of metabolic modeling of NMR 13C isotopic turnover to determine rates of brain metabolism in vivo

Mason, G. F., & Rothman, D. L. (2003) · Metabolic Engineering · doi:10.1016/j.ymben.2003.10.003 · Cited by 54 · see citing works

Regulation of Neurotrophic Factors and Energy Metabolism by Antidepressants in Astrocytes

Martin, J., Magistretti, P. J., & Allaman, I. (2013) · Current Drug Targets · doi:10.2174/1389450111314110009 · Cited by 37 · see citing works

Determination of the Glutamate—Glutamine Cycling Flux Using Two-Compartment Dynamic Metabolic Modeling is Sensitive to Astroglial Dilution

Shen, J., Rothman, D. L., Behar, K. L., & Xu, S. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.102 · Cited by 35 · see citing works

Marked Reductions in Visual Evoked Responses But Not γ-Aminobutyric Acid Concentrations or γ-Band Measures in Remitted Depression

Shaw, A. D., Brealy, J., Richardson, H., Muthukumaraswamy, S. D., Edden, R. A. E., Evans, J., Puts, N. A. J., Singh, K. D., & Keedwell, P. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.032 · Cited by 32 · see citing works

Graded image segmentation of brain tissue in the presence of inhomogeneous radio frequency fields

Mason, G. F., & Rothman, D. L. (2002) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(02)00510-6 · Cited by 20 · see citing works

Simultaneous detection of cerebral metabolism of different substrates by in vivo 13C isotopomer MRS

Xiang, Y., & Shen, J. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.02.021 · Cited by 10 · see citing works

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750 · see citing works

Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments

Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026 · see citing works

Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods

Barth, C., Villringer, A., & Sacher, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00037 · Cited by 731 · see citing works

Targeting glutamate signalling in depression: progress and prospects

Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482 · see citing works

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

Lener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A. C., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.005 · Cited by 468 · see citing works

Candidate biomarkers in psychiatric disorders: state of the field

Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 390 · see citing works

Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies

Moriguchi, S., Takamiya, A., Noda, Y., Horita, N., Wada, M., Tsugawa, S., Plitman, E., Sano, Y., Tarumi, R., ElSalhy, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0252-9 · Cited by 357 · see citing works

Brain GABA levels across psychiatric disorders: A systematic literature review and meta‐analysis of 1 H‐MRS studies

Schür, R. R., Draisma, L. W. R., Wijnen, J. P., Boks, M. P., Koevoets, M., Joëls, M., Klomp, D. W. J., Kahn, R. S., & Vinkers, C. H. (2016) · Human Brain Mapping · doi:10.1002/hbm.23244 · Cited by 356 · see citing works

Glutamate and GABA in autism spectrum disorder—a translational magnetic resonance spectroscopy study in man and rodent models

Horder, J., Petrinovic, M. M., Méndez, M. A., Bruns, A., Takumi, T., Spooren, W. P. J. M., Barker, G. J., Künnecke, B., & Murphy, D. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0155-1 · Cited by 310 · see citing works

Kynurenine pathway in depression: a systematic review and meta-analysis

Ogyu, K., Kubo, K., Noda, Y., Iwata, Y., Tsugawa, S., Omura, Y., Wada, M., Tarumi, R., Plitman, E., Moriguchi, S., et al. (2018) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.023 · Cited by 301 · see citing works

Ketamine Treatment and Global Brain Connectivity in Major Depression

Abdallah, C. G., Averill, L. A., Collins, K. A., Geha, P., Schwartz, J., Averill, C., DeWilde, K. E., Wong, E., Anticevic, A., Tang, C. Y., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.186 · Cited by 300 · see citing works

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects

Abdallah, C. G., De Feyter, H. M., Averill, L. A., Jiang, L., Averill, C. L., Chowdhury, G. M. I., Purohit, P., de Graaf, R. A., Esterlis, I., Juchem, C., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0136-3 · Cited by 229 · see citing works

Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

Du, X., & Pang, T. Y. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00032 · Cited by 211 · see citing works

Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders

Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200 · see citing works

Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder

Sarawagi, A., Soni, N. D., & Patel, A. B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.637863 · Cited by 172 · see citing works

The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence

Zuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157 · see citing works

Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications

Haroon, E., & Miller, A. H. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_40 · Cited by 153 · see citing works

The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment

Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140 · see citing works

Extensive use of monosodium glutamate: a threat to public health?

Niaz, K., Zaplatić, E., & Spoor, J. (2018) · EXCLI journal · doi:10.17179/excli2018-1092 · Cited by 141 · see citing works

The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder

Abdallah, C. G., Jackowski, A., Salas, R., Gupta, S., Sato, J. R., Mao, X., Coplan, J. D., Shungu, D. C., & Mathew, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.49 · Cited by 123 · see citing works

Online effects of transcranial direct current stimulation in real time on human prefrontal and striatal metabolites

Hone-Blanchet, A., Edden, R. A., & Fecteau, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.008 · Cited by 110 · see citing works

Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review

MacDonald, K., Krishnan, A., Cervenka, E., Hu, G., Guadagno, E., & Trakadis, Y. J. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32680 · Cited by 106 · see citing works

O-GlcNAc transferase in astrocytes modulates depression-related stress susceptibility through glutamatergic synaptic transmission

Fan, J., Guo, F., Mo, R., Chen, L., Mo, J., Lu, C., Ren, J., Zhong, Q., Kuang, X., Wen, Y., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci160016 · Cited by 104 · see citing works

Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression

Romeo, B., Choucha, W., Fossati, P., & Rotge, J.-Y. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.160228 · Cited by 94 · see citing works

Abnormality in glutamine–glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study

Hashimoto, K., Bruno, D., Nierenberg, J., Marmar, C. R., Zetterberg, H., Blennow, K., & Pomara, N. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.8 · Cited by 90 · see citing works

Energy metabolism in major depressive disorder: Recent advances from omics technologies and imaging

Gu, X., Ke, S., Wang, Q., Zhuang, T., Xia, C., Xu, Y., Yang, L., & Zhou, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111869 · Cited by 89 · see citing works

Interoception in insula subregions as a possible state marker for depression—an exploratory fMRI study investigating healthy, depressed and remitted participants

Wiebking, C., de Greck, M., Duncan, N. W., Tempelmann, C., Bajbouj, M., & Northoff, G. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00082 · Cited by 90 · see citing works

Ketamine and other potential glutamate antidepressants

Dutta, A., McKie, S., & Deakin, J. F. W. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.028 · Cited by 89 · see citing works

Mitochondrial fission drives neuronal metabolic burden to promote stress susceptibility in male mice

Dong, W.-T., Long, L.-H., Deng, Q., Liu, D., Wang, J.-L., Wang, F., & Chen, J.-G. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00924-6 · Cited by 84 · see citing works

Anterior cingulate Glutamate–Glutamine cycle metabolites are altered in euthymic bipolar I disorder

Soeiro‐de‐Souza, M. G., Henning, A., Machado‐Vieira, R., Moreno, R. A., Pastorello, B., Leite, C. D. C., Vallada, H., & Otaduy, M. C. G. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.09.020 · Cited by 86 · see citing works

Glutamatergic and neural dysfunction in postpartum depression using magnetic resonance spectroscopy

Rosa, C. E., Soares, J. C., de Figueiredo, F. P., Cavalli, R. D. C., Barbieri, M. A., Schaufelberger, M. S., Salmón, C. E. G., Del‐Ben, C. M., & dos Santos, A. C. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.04.008 · Cited by 79 · see citing works

Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry

Morris, G., Walker, A. J., Walder, K. R., Berk, M., Marx, W., Carvalho, A. F., Maes, M. H. J., & Puri, B. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02212-w · Cited by 74 · see citing works

Astrocytic ALKBH5 in stress response contributes to depressive-like behaviors in mice

Guo, F., Fan, J., Liu, J., Kong, P., Ren, J., Mo, J., Lu, C., Zhong, Q., Chen, L.-Y., Jiang, H.-T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48730-2 · Cited by 74 · see citing works

Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response

Li, Q. S., Tian, C., Seabrook, G. R., Drevets, W. C., & Narayan, V. A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.171 · Cited by 68 · see citing works

Macro- and Microscale Stress–Associated Alterations in Brain Structure: Translational Link With Depression

Banasr, M., Sanacora, G., & Esterlis, I. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.004 · Cited by 65 · see citing works

Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile

Johnston, J. N., Greenwald, M. S., Henter, I. D., Kraus, C., Mkrtchian, A., Clark, N. G., Park, L. T., Gold, P. W., Zarate, C. A., & Kadriu, B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103518 · Cited by 66 · see citing works

Advances in Imaging Brain Metabolism

Hyder, F., & Rothman, D. L. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044450 · Cited by 64 · see citing works

Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift

Hertz, L., Rothman, D. L., Li, B., & Peng, L. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00025 · Cited by 66 · see citing works

Antidepressant-like effects of rosmarinic acid through mitogen-activated protein kinase phosphatase-1 and brain-derived neurotrophic factor modulation

Kondo, S., Omri, A. E., Han, J., & Isoda, H. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.001 · Cited by 63 · see citing works

Stress-induced Changes in the S-palmitoylation and S-nitrosylation of Synaptic Proteins*[S]

Zaręba-Kozioł, M., Bartkowiak-Kaczmarek, A., Figiel, I., Krzystyniak, A., Wójtowicz, T., Bijata, M., & Włodarczyk, J. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001581 · Cited by 58 · see citing works

Integrin adhesion in brain assembly: From molecular structure to neuropsychiatric disorders

Jaudon, F., Thalhammer, A., & Cingolani, L. A. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14859 · Cited by 57 · see citing works

Glutamatergic System in Depression and Its Role in Neuromodulatory Techniques Optimization

Khoodoruth, M. A. S., Estudillo‐Guerra, M. A., Pacheco‐Barrios, K., Nyundo, A., Chapa-Koloffon, G., & Ouanes, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.886918 · Cited by 61 · see citing works

Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress

McGowan, J. C., Hill, C., Mastrodonato, A., LaGamma, C. T., Kitayev, A., Brachman, R. A., Narain, N. R., Kiebish, M. A., & Denny, C. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0043-7 · Cited by 57 · see citing works

In vivo ¹³C and ¹H‐[¹³C] MRS studies of neuroenergetics and neurotransmitter cycling, applications to neurological and psychiatric disease and brain cancer

Rothman, D. L., de Graaf, R. A., Hyder, F., Mason, G. F., Behar, K. L., & De Feyter, H. M. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4172 · Cited by 53 · see citing works

7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study

Evans, J. W., Lally, N., An, L., Li, N., Nugent, A. C., Banerjee, D., Snider, S. L., Shen, J., Roiser, J. P., & Zarate, C. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0057-1 · Cited by 53 · see citing works

Low on energy? An energy supply-demand perspective on stress and depression

Østergaard, L., Jørgensen, M. B., & Knudsen, G. M. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.007 · Cited by 52 · see citing works

Metabolomics on depression: A comparison of clinical and animal research

Wang, Y., Cai, X., Ma, Y., Yang, Y., Pan, C., Zhu, X., & Ke, C. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.053 · Cited by 53 · see citing works

Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy: Implications for psychiatric disorders

Xu, H., Zhang, H., Zhang, J., Huang, Q., Shen, Z., & Wu, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.027 · Cited by 51 · see citing works

Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder

Kheirabadi, D., Kheirabadi, G. R., Mirlohi, Z., Tarrahi, M. J., & Norbaksh, A. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001289 · Cited by 52 · see citing works

A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder

Mathew, S. J., Gueorguieva, R. V., Brandt, C., D, M. F. M., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.106 · Cited by 47 · see citing works

Insights from Neuroenergetics into the Interpretation of Functional Neuroimaging: An Alternative Empirical Model for Studying the Brain's Support of Behavior

Shulman, R. G., Hyder, F., & Rothman, D. L. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.145 · Cited by 46 · see citing works

Brain works principle followed by neural information processing: a review of novel brain theory

Wang, R., Wang, Y., Xu, X., Li, Y., & Pan, X. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-023-10520-5 · Cited by 43 · see citing works

Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw

Sharma, S., & Akundi, R. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302120322 · Cited by 42 · see citing works

Does the Change in Glutamate to GABA Ratio Correlate with Change in Depression Severity? A Randomized, Double-Blind Clinical Trial

Narayan, G. A., Hill, K., Wengler, K., He, X., Wang, J.-Y., Yang, J., Parsey, R., & DeLorenzo, C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01730-4 · Cited by 36 · see citing works

Imaging synaptic density in depression

Holmes, S. E., Abdallah, C., & Esterlis, I. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01368-4 · Cited by 39 · see citing works

MEDIAL FRONTAL CORTEX GAMMA-AMINOBUTYRIC ACID CONCENTRATIONS IN PSYCHOSIS AND MOOD DISORDERS: A META-ANALYSIS OF PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDIES

Simmonite, M., Steeby, C. J., & Taylor, S. F. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.08.004 · Cited by 39 · see citing works

Effect of naltrexone pretreatment on ketamine-induced glutamatergic activity and symptoms of depression: a randomized crossover study

Jelen, L. A., Lythgoe, D. J., Stone, J. M., Young, A. H., & Mehta, M. A. (2025) · Nature Medicine · doi:10.1038/s41591-025-03800-w · Cited by 41 · see citing works

Subanesthetic ketamine reverses neuronal and astroglial metabolic activity deficits in a social defeat model of depression

Mishra, P. K., Kumar, A., Behar, K. L., & Patel, A. B. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14544 · Cited by 39 · see citing works

Altered amygdala and hippocampus effective connectivity in mild cognitive impairment patients with depression: a resting-state functional MR imaging study with granger causality analysis

Zheng, L. J., Yang, G. F., Zhang, X. Y., Wang, Y. F., Liu, Y., Zheng, G., Lu, G., Zhang, L. J., & Han, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.15335 · Cited by 38 · see citing works

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder

Du, Y., Wei, J., Zhang, Z., Yang, X., Wang, M., Wang, Y., Qi, X., Zhao, L., Tian, Y., Guo, W., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.644555 · Cited by 37 · see citing works

Ketamin als Anästhetikum bei der Elektrokrampftherapie

Janke, C., Bumb, J. M., Aksay, S. S., Thiel, M., Kranaster, L., & Sartorius, A. (2015) · Der Anaesthesist · doi:10.1007/s00101-015-0027-5 · Cited by 32 · see citing works

Comparative Effect of Intravenous Ketamine and Electroconvulsive Therapy in Major Depression: A Randomized Controlled Trial

Kheirabadi, D., Kheirabadi, G., Vafaie, M., Mirlouhi, Z., & Hajiannasab, R. (2019) · Advanced Biomedical Research · doi:10.4103/abr.abr_166_18 · Cited by 31 · see citing works

Dopamine-Mediated Major Depressive Disorder in the Neural Circuit of Ventral Tegmental Area-Nucleus Accumbens-Medial Prefrontal Cortex: From Biological Evidence to Computational Models

Li, Y., Zhang, B., Pan, X., Wang, Y., Xu, X., Wang, R., & Liu, Z. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.923039 · Cited by 33 · see citing works

Role of mitochondrial uncoupling protein-2 (UCP2) in higher brain functions, neuronal plasticity and network oscillation

Hermes, G., Nagy, D., Waterson, M., Zsarnovszky, A., Varela, L., Hajós, M., & Horváth, T. L. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.04.002 · Cited by 31 · see citing works

Monitoring and modelling the glutamine metabolic pathway: a review and future perspectives

Mirveis, Z., Howe, O. L., Cahill, P. A., Patil, N., & Byrne, H. J. (2023) · Metabolomics · doi:10.1007/s11306-023-02031-9 · Cited by 30 · see citing works

Impaired neuronal and astroglial metabolic activity in chronic unpredictable mild stress model of depression: Reversal of behavioral and metabolic deficit with lanicemine

Mishra, P. K., Adusumilli, M., Deolal, P., Mason, G. F., Kumar, A., & Patel, A. B. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104750 · Cited by 31 · see citing works

Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis

Truong, V., Cheng, P. Z., Lee, H., Lane, T. J., Hsu, T., & Duncan, N. W. (2020) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2020.111238 · Cited by 31 · see citing works

Development of an Enzymatic Biosensor Using Glutamate Oxidase on Organic–Inorganic-Structured, Electrospun Nanofiber-Modified Electrodes for Monosodium Glutamate Detection

Atilgan, H., Unal, B., Yalçınkaya, E. E., Evren, G., Atik, G., Kırbay, F. Ö., Kilic, N. M., & Demirkol, D. O. (2023) · Biosensors · doi:10.3390/bios13040430 · Cited by 30 · see citing works

Potential involvement of the mitochondrial unfolded protein response in depressive-like symptoms in mice

Kambe, Y., & Miyata, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.006 · Cited by 30 · see citing works

Glutamine Supplementation Ameliorates Chronic Stress-induced Reductions in Glutamate and Glutamine Transporters in the Mouse Prefrontal Cortex

Baek, J. H., Vignesh, A., Son, H., Lee, D. H., Roh, G. S., Kang, S. S., Cho, G. J., Choi, W. S., & Kim, H. J. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.2.270 · Cited by 29 · see citing works

A Resting-State Functional MR Imaging and Spectroscopy Study of the Dorsal Hippocampus in the Chronic Unpredictable Stress Rat Model

Magalhães, R. J. D. S., Novais, A., Barrière, D. A., Marques, P., Marques, F., Sousa, J. C., Cerqueira, J., Cachia, A., Jay, T. M., Bottlaender, M., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2192-18.2019 · Cited by 28 · see citing works

Brain and body energy metabolism and potential for treatment of psychiatric disorders

Andreazza, A. C., Barros, L. F., Behnke, A., Ben‐Shachar, D., Berretta, S., Chouinard, V., Kim, Q., Thanarajah, S. E., Ehrenreich, H., Falkai, P., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00422-6 · Cited by 27 · see citing works

EAAT2 as a Research Target in Bipolar Disorder and Unipolar Depression: A Systematic Review

Blacker, C. J., Millischer, V., Webb, L. M., Ho, A. M., Schalling, M., Frye, M. A., & Veldić, M. (2019) · Complex Psychiatry · doi:10.1159/000501885 · Cited by 27 · see citing works

Probiotics for adults with major depressive disorder compared with antidepressants: a systematic review and network meta-analysis

Zhao, S., Liang, S., Tao, J., Ye, P., Chen, S., Wai, H. K.-F., Chung, F.-Y., Sin, Z. Y., Wong, M. K. L., Haqq, A. M., et al. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad171 · Cited by 28 · see citing works

The role of neurotransmitters in mediating the relationship between brain alterations and depressive symptoms in patients with inflammatory bowel disease

Wang, J., Liu, G., Xu, K., Ai, K., Huang, W., & Zhang, J. (2023) · Human Brain Mapping · doi:10.1002/hbm.26439 · Cited by 27 · see citing works

Dietary glutamate and the brain: In the footprints of a Jekyll and Hyde molecule

Onaolapo, A. Y., & Onaolapo, O. J. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.07.001 · Cited by 25 · see citing works

Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress

Zhu, X., Li, T., Hu, E., Duan, L., Zhang, C., Wang, Y., Tang, T., Yang, Z., & Fan, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.791097 · Cited by 25 · see citing works

The neurobiology of depression

Binakaj, Z., Stojkov, S., Gafić, E., Čongo, S., Đurić, S., & Binakaj, E. (2019) · Timocki medicinski glasnik · doi:10.5937/tmg1903118b · Cited by 25 · see citing works

Retinal function and preclinical risk traits in children and adolescents at genetic risk of schizophrenia and bipolar disorder

Maziade, M., Bureau, A., Jomphe, V., & Gagné, A.-M. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110432 · Cited by 24 · see citing works

Exploration for biomarkers of postpartum depression based on metabolomics: A systematic review

Li, S., Yang, Z., Yao, M., Shen, Y., Zhu, H., Jiang, Y., Ji, Y., & Yin, J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.043 · Cited by 24 · see citing works

Development of psychopathology in deployed armed forces in relation to plasma GABA levels

Schür, R. R., Boks, M. P., Geuze, E., Prinsen, H. C. M. T., Verhoeven‐Duif, N. M., Joëls, M., Kahn, R. S., Vermetten, E. H. G. J. M., & Vinkers, C. H. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.014 · Cited by 24 · see citing works

Brain network reorganization differs in response to stress in rats genetically predisposed to depression and stress-resilient rats

Gass, N., Becker, R., Schwarz, A. J., Weber‐Fahr, W., von Hohenberg, C. C., Vollmayr, B., & Sartorius, A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.233 · Cited by 24 · see citing works

Early life stress and glutamate neurotransmission in major depressive disorder

Averill, L. A., Abdallah, C. G., Fenton, L. R., Fasula, M. K., Jiang, L., Rothman, D. L., Mason, G. F., & Sanacora, G. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.03.015 · Cited by 26 · see citing works

Prefrontal Glutamate Neurotransmission in PTSD: A Novel Approach to Estimate Synaptic Strength in Vivo in Humans

Averill, L. A., Jiang, L., Purohit, P., Coppoli, A., Averill, C. L., Roscoe, J., Kelmendi, B., Feyter, H. M. D., de Graaf, R. A., Gueorguieva, R. V., et al. (2022) · Chronic Stress · doi:10.1177/24705470221092734 · Cited by 22 · see citing works

Longer-term open-label study of adjunctive riluzole in treatment-resistant depression

Sakurai, H., Dording, C., Yeung, A., Foster, S., Jain, F., Chang, T., Trinh, N.-H., Bernard, R., Boyden, S., Iqbal, S. Z., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.065 · Cited by 20 · see citing works

Fecal Microbial and Metabolomic Change during treatment course for depression: An Observational Study

Kurokawa, S., Tomizawa, Y., Miyaho, K., Ishii, D., Takamiya, A., Ishii, C., Sanada, K., Fukuda, S., Mimura, M., & Kishimoto, T. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.05.009 · Cited by 19 · see citing works

Clinical overview of NMDA-R antagonists and clinical practice

Davoudian, P. A., & Wilkinson, S. T. (2020) · Advances in Pharmacology · doi:10.1016/bs.apha.2020.04.004 · Cited by 10 · see citing works

Fecal metabolomics combined with metagenomics sequencing to analyze the antidepressant mechanism of Yueju Wan

Qu, Z., Wu, S., Zheng, Y., Bing, Y., Liu, X., Li, S., Li, W., & Zou, X. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115807 · Cited by 17 · see citing works

In Vivo 13C Magnetic Resonance Spectroscopy for Assessing Brain Biochemistry in Health and Disease

Mandal, P. K., Roy, R. G., Samkaria, A., Maroon, J. C., & Arora, Y. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03538-8 · Cited by 17 · see citing works

UPLC-MS/MS-based profiling of 31 neurochemicals in the mouse brain after treatment with the antidepressant nefazodone

Kim, S. S., Lee, H.-Y., Song, J. S., Bae, M., & Ahn, S. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106580 · Cited by 17 · see citing works

The Impact of Theta-Burst Stimulation on Cortical GABA and Glutamate in Treatment-Resistant Depression: A Surface-Based MRSI Analysis Approach

Spurny‐Dworak, B., Godbersen, G. M., Reed, M. B., Unterholzner, J., Vanicek, T., Baldinger, P., Hahn, A., Kranz, G. S., Bogner, W., Lanzenberger, R. R., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.913274 · Cited by 15 · see citing works

Beyond Protein Building Blocks: A Review of Biological Roles and Therapeutic Potential of Free Amino Acids

Petkova, D., Stoyanova, S., Dinkov, G., & Bogdanov, M. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311264 · Cited by 16 · see citing works

Emerging application of metabolomics on Chinese herbal medicine for depressive disorder

Gu, X., Gao, X., Cheng, J., Xia, C., Xu, Y., Yang, L., & Zhou, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111866 · Cited by 14 · see citing works

D-arabinose acts as antidepressant by activating the ACSS2-PPARγ/TFEB axis and CRTC1 transcription

Guo, Y., Chen, N., Zhao, M., Cao, B., Zhu, F., Guo, C., Shi, Y., Wang, Q., Li, Y., & Zhang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107136 · Cited by 14 · see citing works

Multi-omics Analysis of Energy Metabolism Pathways Across Major Psychiatric Disorders

Zou, S.-Q., Mendes-Silva, A., Santos, F. D. D., Ebrahimi, M., Kennedy, J. L., & Gonçalves, V. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05133-8 · Cited by 12 · see citing works

Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression

Asch, R. H., Abdallah, C. G., Carson, R. E., & Esterlis, I. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-024-01913-3 · Cited by 13 · see citing works

Examining cognitive control and reward interactions in adolescent externalizing symptoms

Rodriguez-Thompson, A., Meyer, K. M., Davidow, J. Y., Dijk, K. R. A. V., Santillana, R. M., Snyder, J., Bustamante, C. M. V., Hollinshead, M. O., Rosen, B. R., Somerville, L. H., et al. (2020) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2020.100813 · Cited by 13 · see citing works

TMS-evoked potential in the dorsolateral prefrontal cortex to assess the severity of depression disease: a TMS-EEG study

Li, X., Chen, M., Liu, Q., Zheng, C., Yu, C., Hou, G., Chen, Z., Chen, Y., Chen, Y., Zhu, G., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1207020 · Cited by 13 · see citing works

Novel rapid-acting antidepressants: molecular and cellular signaling mechanisms

Thomas, A. M., & Duman, R. S. (2017) · Neuronal Signaling · doi:10.1042/ns20170010 · Cited by 14 · see citing works

Dysregulation of the Glutamatergic System in Major Depressive Disorder

Cooper, T. M., & Iosifescu, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-58131-8.00012-4 · Cited by 1 · see citing works

What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder

Sanacora, G. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0780 · Cited by 12 · see citing works

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

Niciu, M. J., Ionescu, D. F., Richards, E. M., & Zarate, C. A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1130-x · Cited by 157 · see citing works

Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies

Li, C.-T., Yang, K.-C., & Lin, W.-C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00767 · Cited by 147 · see citing works

P314. Aberrant Connectivity Across Functional Networks Relates to Levels of Glutamatergic Metabolites in Major Depression

Gonsalves, M. A., White, T. L., Barredo, J., DeMayo, M. M., Harris, A. D., Hindley, L. E., DeLuca, E., & Carpenter, L. L. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.02.550